Anteris Technologies Global (AVR) Competitors $4.76 -0.19 (-3.84%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock AVR vs. AXGN, EMBC, IRMD, BVS, SIBN, BFLY, RXST, AVNS, CBLL, and KIDSShould you be buying Anteris Technologies Global stock or one of its competitors? The main competitors of Anteris Technologies Global include AxoGen (AXGN), Embecta (EMBC), Iradimed (IRMD), Bioventus (BVS), SI-BONE (SIBN), Butterfly Network (BFLY), RxSight (RXST), Avanos Medical (AVNS), CeriBell (CBLL), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry. Anteris Technologies Global vs. AxoGen Embecta Iradimed Bioventus SI-BONE Butterfly Network RxSight Avanos Medical CeriBell OrthoPediatrics AxoGen (NASDAQ:AXGN) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, community ranking, profitability, analyst recommendations, earnings and dividends. Do analysts rate AXGN or AVR? AxoGen currently has a consensus target price of $22.60, indicating a potential upside of 36.85%. Anteris Technologies Global has a consensus target price of $16.50, indicating a potential upside of 246.64%. Given Anteris Technologies Global's higher probable upside, analysts clearly believe Anteris Technologies Global is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AxoGen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Anteris Technologies Global 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer AXGN or AVR? AxoGen received 453 more outperform votes than Anteris Technologies Global when rated by MarketBeat users. However, 100.00% of users gave Anteris Technologies Global an outperform vote while only 72.89% of users gave AxoGen an outperform vote. CompanyUnderperformOutperformAxoGenOutperform Votes45772.89% Underperform Votes17027.11% Anteris Technologies GlobalOutperform Votes4100.00% Underperform VotesNo Votes Do institutionals and insiders hold more shares of AXGN or AVR? 80.3% of AxoGen shares are held by institutional investors. 7.0% of AxoGen shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is AXGN or AVR more profitable? Anteris Technologies Global has a net margin of 0.00% compared to AxoGen's net margin of -7.91%. Anteris Technologies Global's return on equity of 0.00% beat AxoGen's return on equity.Company Net Margins Return on Equity Return on Assets AxoGen-7.91% -14.91% -7.49% Anteris Technologies Global N/A N/A N/A Does the media favor AXGN or AVR? In the previous week, AxoGen had 2 more articles in the media than Anteris Technologies Global. MarketBeat recorded 7 mentions for AxoGen and 5 mentions for Anteris Technologies Global. AxoGen's average media sentiment score of 1.33 beat Anteris Technologies Global's score of 1.32 indicating that AxoGen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AxoGen 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Anteris Technologies Global 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, AXGN or AVR? Anteris Technologies Global has lower revenue, but higher earnings than AxoGen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxoGen$187.34M3.91-$21.72M-$0.22-75.07Anteris Technologies Global$2.71M63.25N/AN/AN/A SummaryAxoGen beats Anteris Technologies Global on 7 of the 13 factors compared between the two stocks. Get Anteris Technologies Global News Delivered to You Automatically Sign up to receive the latest news and ratings for AVR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVR vs. The Competition Export to ExcelMetricAnteris Technologies GlobalSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$171.47M$9.20B$5.49B$7.95BDividend YieldN/A1.64%5.11%4.22%P/E RatioN/A19.3422.6218.58Price / Sales63.2571.03397.85103.49Price / CashN/A19.6738.1834.62Price / BookN/A5.036.744.25Net IncomeN/A$284.66M$3.22B$248.18M7 Day Performance-7.39%0.61%1.59%1.36%1 Month Performance40.00%2.79%4.09%3.85%1 Year PerformanceN/A-16.20%15.98%5.37% Anteris Technologies Global Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVRAnteris Technologies GlobalN/A$4.76-3.8%$16.50+246.6%N/A$171.47M$2.71M0.00138News CoveragePositive NewsAXGNAxoGen2.8984 of 5 stars$16.16+3.5%$22.60+39.9%+153.8%$716.60M$187.34M-50.50450Upcoming EarningsPositive NewsEMBCEmbecta4.5882 of 5 stars$11.75+4.5%$20.33+73.0%+20.3%$683.07M$1.11B11.751,900Positive NewsIRMDIradimed4.8043 of 5 stars$53.13+0.8%$72.00+35.5%+29.1%$675.55M$73.24M35.42110Positive NewsBVSBioventus3.279 of 5 stars$7.73+1.8%$15.00+94.0%+84.6%$633.43M$573.28M-12.671,200Positive NewsSIBNSI-BONE4.1734 of 5 stars$14.39+4.1%$24.40+69.6%-4.3%$610.90M$167.18M-15.64350Upcoming EarningsNews CoveragePositive NewsBFLYButterfly Network2.5525 of 5 stars$2.48+2.9%$3.00+21.0%+198.6%$602.45M$82.06M-5.39460Upcoming EarningsInsider TradeNews CoveragePositive NewsRXSTRxSight2.6454 of 5 stars$14.73+1.8%$37.60+155.3%-71.8%$596.43M$139.93M-17.75220Upcoming EarningsHigh Trading VolumeAVNSAvanos Medical2.164 of 5 stars$12.50+0.6%N/A-30.6%$575.04M$687.80M36.764,040Upcoming EarningsShort Interest ↑Analyst RevisionHigh Trading VolumeCBLLCeriBell2.2024 of 5 stars$15.49+2.7%$32.50+109.8%N/A$555.60M$65.44M0.00N/ANews CoverageKIDSOrthoPediatrics4.1396 of 5 stars$21.76+4.8%$37.00+70.0%-29.7%$528.49M$204.73M-17.69200Upcoming EarningsPositive News Related Companies and Tools Related Companies AXGN Alternatives EMBC Alternatives IRMD Alternatives BVS Alternatives SIBN Alternatives BFLY Alternatives RXST Alternatives AVNS Alternatives CBLL Alternatives KIDS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AVR) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anteris Technologies Global Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Anteris Technologies Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
